Cramer Pamela J. bought RYTM

November 10, 2025 · Form 4 insider transaction

Cramer Pamela J. bought 3,515 shares of Rhythm Pharmaceuticals, Inc. at $6.80 per share, a transaction worth $23.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.